下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>
多维分析
公司估值 资金追踪 卖空分析
06185 康希诺生物
88.000
+4.250+5.07%
显示同比
不显示
隐藏空行
(Q3)2022/03/31(FY)2021/12/31(Q9)2021/09/30(Q6)2021/06/30
Per Share IndicaTor
Operating Cash Flow Per Share
-4920.79% -2.9805 541.81% 9.9575 862.58% 6.0312 767.32% 3.7325
Cash Flow Per Share
-764.56% -7.3827 -74.86% 5.1564 -70.18% 2.0315 -87.02% 0.2132
Operating Income Per Share
11.49% 2.4883 23768.23% 21.2525 57266.73% 14.9693 -- 10.012
Net Asset Per Share
38.14% 40.0354 35.57% 39.5178 24.49% 35.9956 403.28% 34.0769
Basic Earning Per Share
951.07% 0.6042 563.23% 9.4667 828.9% 6.4701 1004.47% 4.5549
Diluted  Earning Per Share
951.07% 0.6042 563.23% 9.4667 828.9% 6.4701 1004.47% 4.5549
Profitability
Gross Profit Ratio
35.13% 70.267% 173.26% 69.847% -27.48% 66.083% -- 69.683%
Operating Profit Ratio
803.64% 24.406% 102.06% 44.459% 101.35% 41.975% -- 38.921%
Net Profit Ratio
778.23% 22.889% 102.07% 44.354% 101.39% 43.227% -- 45.460%
Earning Before Tax Ratio
817.39% 24.210% 102.11% 45.045% 101.35% 41.817% -- 40.594%
ROE
755.06% 1.521% 358.92% 27.560% 536.51% 19.866% 302.61% 14.397%
ROA
618.75% 1.024% 320.64% 20.775% 463.21% 15.189% 291.28% 11.075%
Yield Quality
Operating Profit To Total Profits
-- 100.810% -- 98.700% -- 100.377% -- 95.877%
Tax To Total Profits
-- -5.459% -- -1.534% -- 3.372% -- 11.986%
Operating Cash To Total Revenue
-4403.32% -119.784% 101.85% 46.853% 101.33% 40.290% -- 37.281%
Capital Structure
Debt Assets Ratio
50.08% 28.103% 179.13% 28.013% 465.97% 31.833% 61.85% 31.558%
Equity Multipler
19.67% 1.4853 33.61% 1.4852 38.45% 1.467 17.62% 1.4611
Debt Equity Ratio
69.66% 39.087% 248.84% 38.914% 683.57% 46.698% 90.36% 46.109%
Current Assets To tatal Assets
-0.99% 76.441% -2.61% 78.236% -4.78% 78.730% 111.35% 80.272%
Non Current Assets To Total Assets
3.34% 23.559% 10.64% 21.764% 22.83% 21.270% -68.19% 19.728%
Current Liabilities To tatal Liabilities
19.67% 82.725% 41.78% 86.431% 88.5% 89.225% 75.47% 87.107%
Non Current Liabilities To Total Liabilities
-44.04% 17.275% -65.24% 13.569% -79.54% 10.775% -74.4% 12.893%
Solvency
Current Ratio
-44.87% 3.2881 -75.39% 3.2313 -91.07% 2.7719 -25.58% 2.9202
Quick Ratio
-48.64% 2.8838 -76.99% 2.9267 -91.6% 2.5811 -27.35% 2.7366
Operating Profit To Current Liabilities
364.23% 0.0439 168.48% 0.6649 142.05% 0.4189 138.33% 0.2847
Operrating Cash Flow To Current Liabilities
-1591.06% -0.2156 161.63% 0.7007 141.47% 0.4021 139.69% 0.2727
Share Equity Without Minority Interest To Total Liabilities
-44.32% 2.3957 -73.19% 2.4036 -87.24% 2.1414 -47.47% 2.1688
Operating Cash Flow To Total Liabilities
-1923.73% -0.1784 187.38% 0.6056 178.18% 0.3588 169.65% 0.2376
Operating Profit To Total Liabilities
416.18% 0.0363 197.09% 0.5747 179.27% 0.3738 167.25% 0.248
Operating Capacity
Current Assets Turnover(T)
-34.36% 0.0545 9723.66% 0.5908 24435.73% 0.4429 -- 0.3034
Fixed Assets Turnover(T)
-65.98% 0.3191 11518.2% 3.0471 20429.79% 3.5053 -- 1.8083
Total Assets Turnover(T)
-35.48% 0.0421 10499.98% 0.4666 25946.33% 0.3514 -- 0.2436
Growth Ability
Operating Revenue GR 3Y
-- -- -- 406956.127% -- -- -- --
Operating Profit GR 3Y
-- -- 401.17% 1578.318% -- -- 650.02% 1676.814%
EBT GR 3Y
-- -- 413.17% 1601.004% -- -- 858.27% 1747.048%
Net Profit GR 3Y
-- -- 408.66% 1577.985% -- -- 943.95% 1944.456%
Net Profit Attributable To The Parent Company GR 3Y
-- -- 409.77% 1583.646% -- -- 943.95% 1944.456%
Total Assets GR 3Y
-- -- 123.07% 1495.159% -- -- -- 1082.351%
Share Equity Without Minority Interest GR 3Y
-- -- 80.27% 1601.720% -- -- -- 1127.510%
Equity GR 3Y
-- -- 93.51% 1719.389% -- -- -- 1127.510%
Total Liabilities GR 3Y
-- -- 601.05% 1111.470% -- -- -- 994.984%
Basic Earning Per Share GR 3Y
-- -- 465.37% 1021.639% -- -- 1346.03% 1229.469%
Net Assets Per Share GR 3Y
-- -- -- 1006.864% -- -- -- --
Other Indicators
Currency Unit
港元港元港元港元

Q6、Q9、FY为累计季报:Q6 为中期报告;Q9 为第三季报;FY为年报。

环比数据来源于季报,环比 = (本期 - 上期)/上期 * 100%

公司概况 更多
康希诺生物股份公司(原名:天津康希诺生物技术有限公司)是一家主要从事人用疫苗产品的研发、生产及商品化业务的中国公司。该公司的核心产品包括两种在研疫苗,即在研MCV4及在研MCV2。该公司主要在中国境内开展业务。
董事长: Xuefeng YU
所属市场: 香港主板
上市日期: 2019/03/28
富途热股榜
港股美股沪深
交易热度搜索热度资讯热度
名称代码最新价涨跌幅

加载中...

自选
回到顶部